GlassScriptPhysician profile
Stephanie Madden
NPI 1487103941
$1,242.34
in general payments reported to CMS, 2019-2025
8 companies · $291 in 2025
The $291 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $104 · 2023: $301 · 2024: $547 · 2025: $291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,138.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,138.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $617.48 | 2022-2025 | Atriclip Laa Exclusion System |
| Medtronic, INC. | $207.34 | 2024-2025 | Corevalve Evolut R |
| Abiomed | $184.18 | 2024 | Impella |
| Edwards Lifesciences Corporation | $108.07 | 2022-2025 | Sapien 3 Ultra Resilia |
| Zimmer Biomet Holdings, INC. | $45.63 | 2024-2025 | Sternalock Blu System, Venapax |
| Pfizer INC. | $32.00 | 2022-2024 | |
| Getinge USA Sales, LLC | $25.32 | 2025 | Vasoview Hemopro 2 |
| Smith+Nephew, INC. | $22.32 | 2024 | Pico 14 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Madden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.